These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9181648)

  • 1. Measles antibodies and herd immunity in 20- and 40-year-old Norwegians.
    Flugsrud LB; Rłd TO; Aasen S; Berdal BP
    Scand J Infect Dis; 1997; 29(2):137-40. PubMed ID: 9181648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of measles among Norwegian military conscripts in 2004.
    Vainio K; Samdal HH; Anestad G; Skutlaberg DH; Bransdal KT; Mundal R; Aaberge I
    Eur J Clin Microbiol Infect Dis; 2007 Mar; 26(3):217-20. PubMed ID: 17273828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low percentages of measles vaccination coverage with two doses of vaccine and low herd immunity levels explain measles incidence and persistence of measles in the European Union in 2017-2018.
    Plans-Rubió P
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1719-1729. PubMed ID: 31289949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
    Tischer A; Gerike E
    Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Waning immunity and subclinical measles infections in England.
    Glass K; Grenfell BT
    Vaccine; 2004 Sep; 22(29-30):4110-6. PubMed ID: 15364464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles active and passive immunity in a worldwide perspective.
    Black FL
    Prog Med Virol; 1989; 36():1-33. PubMed ID: 2685909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Present anti-measles immunity in Jordan.
    Bdour S; Batayneh N
    Vaccine; 2001 Jul; 19(28-29):3865-9. PubMed ID: 11427259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress towards measles elimination in Singapore.
    Ho HJ; Low C; Ang LW; Cutter JL; Tay J; Chan KP; Ooi PL; Thoon KC; Goh KT
    Vaccine; 2014 Dec; 32(51):6927-6933. PubMed ID: 25444818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of undocumented and excluded vaccinations on measles immunity in a university population.
    Herold AH; Roetzheim RG; Young DL; Anderson MJ; Blair RC; Mockler B
    J Fla Med Assoc; 1993 Mar; 80(3):173-7. PubMed ID: 8487024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of viral specific CD4 T cells to in vitro stimulation with vaccine and wild measles virus strains in vaccinated and naturally infected subjects.
    Cześcik A; Dunal-Szczepaniak M; Trzcińska A; Siennicka J
    Pol J Microbiol; 2014; 63(2):203-9. PubMed ID: 25115114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of measles in England and Wales since the 1994 vaccination campaign.
    Gay N; Ramsay M; Cohen B; Hesketh L; Morgan-Capner P; Brown D; Miller E
    Commun Dis Rep CDR Rev; 1997 Feb; 7(2):R17-21. PubMed ID: 9046124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus.
    Christenson B; Böttiger M
    Vaccine; 1994 Feb; 12(2):129-33. PubMed ID: 8147093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options.
    Babad HR; Nokes DJ; Gay NJ; Miller E; Morgan-Capner P; Anderson RM
    Epidemiol Infect; 1995 Apr; 114(2):319-44. PubMed ID: 7705494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The epidemiological efficacy of mass vaccination against measles among the troops].
    Sibilev VI; Shevtsova VA; Tiasto EA
    Voen Med Zh; 1994 Feb; (2):50-1, 80. PubMed ID: 8165796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles immunity in young Australian adults.
    Gidding HF; Gilbert GL
    Commun Dis Intell Q Rep; 2001 Aug; 25(3):133-6. PubMed ID: 11596715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months.
    Gans HA; Arvin AM; Galinus J; Logan L; DeHovitz R; Maldonado Y
    JAMA; 1998 Aug; 280(6):527-32. PubMed ID: 9707142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study on the level of antibody against measles through maternal-fetal transfer and the immuno-response to measles vaccine among 4 to 7 month olds].
    Liu BY; Feng ZX; Xu AQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Oct; 16(5):263-5. PubMed ID: 8706090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006.
    Gagneur A; Pinquier D; Aubert M; Balu L; Brissaud O; De Pontual L; Gras Le Guen C; Hau-Rainsard I; Mory O; Picherot G; Stephan JL; Cohen B; Caulin E; Soubeyrand B; Reinert P
    Clin Vaccine Immunol; 2008 Dec; 15(12):1845-50. PubMed ID: 18815232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles virus genotyping an important tool in measles outbreak investigation in Norway, 2011.
    Vainio K; Steen TW; Arnesen TM; Rønning K; Ånestad G; Dudman S
    Euro Surveill; 2012 Dec; 17(50):. PubMed ID: 23241234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.